Home » Stocks » ATR

AptarGroup, Inc. (ATR)

Stock Price: $138.83 USD -0.62 (-0.44%)
Updated Jan 15, 2021 4:00 PM EST - Market closed
Market Cap 8.99B
Revenue (ttm) 2.85B
Net Income (ttm) 209.34M
Shares Out 64.56M
EPS (ttm) 3.15
PE Ratio 44.07
Forward PE 32.57
Dividend $1.44
Dividend Yield 1.04%
Trading Day January 15
Last Price $138.83
Previous Close $139.45
Change ($) -0.62
Change (%) -0.44%
Day's Open 139.04
Day's Range 138.37 - 141.33
Day's Volume 149,314
52-Week Range 83.15 - 141.33

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
Business Wire - 4 days ago

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active packaging solutions, today declared a quarterly cash...

Zacks Investment Research - 4 days ago

Demand for AptarGroup's (ATR) pharmaceutical products and sanitizers, liquid soaps and disinfectants makes the stock a prudent investment pick.

Zacks Investment Research - 6 days ago

SON vs. ATR: Which Stock Is the Better Value Option?

Other stocks mentioned: SON
Business Wire - 1 week ago

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active packaging solutions, has recently published new poli...

Business Wire - 1 week ago

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active packaging solutions, announced the dates and times o...

Zacks Investment Research - 1 month ago

Triggered by the pandemic, increasing demand for pharmaceutical products and sanitizers, liquid soaps and disinfectants featuring AptarGroup's (ATR) solutions is driving its shares.

Business Wire - 1 month ago

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active packaging solutions, has recently been recognized wi...

Business Wire - 1 month ago

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active packaging solutions, has been recognized for its lea...

Zacks Investment Research - 1 month ago

AptarGroup (ATR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Business Wire - 1 month ago

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active packaging solutions, has been named one of “America'...

Business Wire - 1 month ago

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE:ATR) a global leader in drug delivery, consumer product dispensing and active packaging solutions, has been named one of the “Most R...

Zacks Investment Research - 1 month ago

Pandemic-induced demand for pharmaceutical products is likely to drive AptarGroup's (ATR) Pharma segment, while demand in personal care market and home care market will aid the Beauty + Home s...

Zacks Investment Research - 1 month ago

Investors can retain AptarGroup (ATR) stock in their portfolio for the time being on upbeat prospects.

Zacks Investment Research - 2 months ago

AptarGroup's (ATR) top and bottom lines improve on solid growth in the Pharma segment as well as in the food, personal care and home care markets during the July-September period.

Zacks Investment Research - 2 months ago

PKG vs. ATR: Which Stock Is the Better Value Option?

Other stocks mentioned: PKG
Seeking Alpha - 2 months ago

AptarGroup's (ATR) CEO Stephan Tanda on Q3 2020 Results - Earnings Call Transcript

Zacks Investment Research - 2 months ago

AptarGroup (ATR) delivered earnings and revenue surprises of 19.05% and 7.51%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

Business Wire - 2 months ago

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE:ATR) today reported third quarter results for 2020 and provided an update related to COVID-19 including the Company's continued supp...

Zacks Investment Research - 2 months ago

AptarGroup's (ATR) third-quarter 2020 results are likely to reflect higher demand for pharmaceutical products amid the COVID-19 pandemic. However, weak beauty products sales will negate these ...

Zacks Investment Research - 2 months ago

AptarGroup (ATR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research - 3 months ago

SON vs. ATR: Which Stock Is the Better Value Option?

Other stocks mentioned: SON
Business Wire - 3 months ago

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active packaging solutions, today declared a quarterly cash...

Zacks Investment Research - 3 months ago

AptarGroup (ATR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks Investment Research - 3 months ago

BERY vs. ATR: Which Stock Is the Better Value Option?

Other stocks mentioned: BERY
CNBC Television - 4 months ago

How demand for sanitizers created a dispenser and packaging shortage

CNBC's Kelly Evans discusses how the sanitizer boom has impacted dispenser and packaging manufacturing with Stephan Tandy, CEO of Aptar Group.

Seeking Alpha - 4 months ago

The company has handled COVID-19 fairly well and has made it through the worst of it with minimal damage.

Zacks Investment Research - 4 months ago

AptarGroup (ATR) reported earnings 30 days ago. What's next for the stock?

Zacks Investment Research - 4 months ago

AptarGroup (ATR) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.

Business Wire - 4 months ago

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc.

Zacks Investment Research - 5 months ago

Investors can retain AptarGroup (ATR) stock in their portfolio for the time being on upbeat prospects.

Zacks Investment Research - 5 months ago

BERY vs. ATR: Which Stock Is the Better Value Option?

Other stocks mentioned: BERY
Zacks Investment Research - 5 months ago

AptarGroup (ATR) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks Investment Research - 5 months ago

AptarGroup's (ATR) core sales growth in the Pharma segment in Q2 is partly offset by decline in core sales in other segments due to the coronavirus pandemic.

Seeking Alpha - 5 months ago

AptarGroup Inc. (ATR) CEO Stephan Tanda on Q2 2020 Results - Earnings Call Transcript

Zacks Investment Research - 5 months ago

AptarGroup (ATR) delivered earnings and revenue surprises of 17.65% and 6.76%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Business Wire - 5 months ago

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc.

Zacks Investment Research - 5 months ago

AptarGroup (ATR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Zacks Investment Research - 5 months ago

AptarGroup (ATR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks Investment Research - 5 months ago

AptarGroup (ATR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research - 6 months ago

AMCR vs. ATR: Which Stock Is the Better Value Option?

Other stocks mentioned: AMCR
Business Wire - 6 months ago

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active packaging solutions, announced today that Kimberly Y...

Zacks Investment Research - 6 months ago

AptarGroup's (ATR) Q2 performance might have been adversely impacted by lackluster demand due to the coronavirus crisis-related near-term uncertainties.

InvestorPlace - 6 months ago

Rubber and plastics stocks have lagged the market rebound. Commodity prices are a concern, but these five stocks have hopes of catching up.

Other stocks mentioned: BERY, MGDDY, MYE, TSE
Zacks Investment Research - 6 months ago

GPK vs. ATR: Which Stock Is the Better Value Option?

Other stocks mentioned: GPK
Zacks Investment Research - 7 months ago

AptarGroup (ATR) reported earnings 30 days ago. What's next for the stock?

Zacks Investment Research - 7 months ago

GPK vs. ATR: Which Stock Is the Better Value Option?

Other stocks mentioned: GPK
Zacks Investment Research - 8 months ago

AptarGroup (ATR) registers solid core sales growth in the Pharma segment in Q1, partly offset by decline in core sales in other segments on the coronavirus crisis.

Seeking Alpha - 8 months ago

AptarGroup Inc. (ATR) CEO Stephan Tanda on Q1 2020 Results - Earnings Call Transcript

Zacks Investment Research - 8 months ago

AptarGroup (ATR) delivered earnings and revenue surprises of 5.68% and 0.76%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research - 8 months ago

AptarGroup (ATR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

About ATR

AptarGroup provides a range of packaging, dispensing, and sealing solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Beauty + Home, Pharma, and Food + Beverage. The Beauty + Home segment primarily sells pumps, closures, aerosol valves, accessories, and sealing solutions to the personal care and home care markets; and pumps and decorative components components to the beauty market. The Pharma segment provide... [Read more...]

Industry
Packaging & Containers
IPO Date
Apr 21, 1993
CEO
Stephan Tanda
Employees
14,000
Stock Exchange
NYSE
Ticker Symbol
ATR
Full Company Profile

Financial Performance

In 2019, AptarGroup's revenue was $2.86 billion, an increase of 3.44% compared to the previous year's $2.76 billion. Earnings were $242.20 million, an increase of 24.37%.

Financial Statements

Analyst Forecasts

According to 11 analysts, the average rating for AptarGroup stock is "Buy." The 12-month stock price forecast is 143.29, which is an increase of 3.21% from the latest price.

Price Target
$143.29
(3.21% upside)
Analyst Consensus: Buy